A phase Ib/II trial of PEP503 (NBTXR3, radioenhancer) with radiotherapy and chemotherapy in patients with rectal cancer

Nanomedicine, Ahead of Print.

Source: Nanomedicine - May 11, 2023 Category: Nanotechnology Authors: Ching-Wen Huang Huang-Ming Hu Wen-Hung Hsu Chiao-Yun Chen Ming-Yii Huang Chou-Pin Chen Po-Li Wei Bor-Nian Shen Jaw-Yuan Wang Source Type: research